Study 3, AGM vaccine dose-down study (research-grade) for "A Subunit Vaccine (HeV-sG) to Protect Against Nipah and Hendra Disease"

Project: Other project

StatusActive
Effective start/end date11/1/192/28/21

Funding

  • Profectus BioSciences Incorporated: $488,976.00